Investigating the effects of placebo on stroke recovery
Official title: Mechanisms of Open and Hidden Placebo in Stroke Recovery
Run by Spaulding Rehabilitation Hospital · NCT05832567 · Data updated 2026-11-12
This study is testing how different types of placebo treatments can help people recovering from a stroke feel better and improve their brain function.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 56 (estimated) |
| Sponsor | Spaulding Rehabilitation Hospital Academic / other |
| Locations | 1 site (Cambridge, Massachusetts) |
| Status | Recruiting |
| Started | September 11, 2023 |
| Main results expected | June 1, 2026 |
| Study ends | December 30, 2026 |
| Registry record updated | July 14, 2026 |
| Trial ID | NCT05832567 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 or older with hemiparesis due to chronic stroke lasting six months or more.
✕Probably not a fit
Patients with specific contraindications to TMS or those with severe depression may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial aims to explore the specific neural signatures associated with open and hidden placebo effects in individuals recovering from stroke. By examining how these placebo effects influence brain excitability and connectivity, the study seeks to enhance rehabilitation therapies for stroke patients. A total of 56 chronic stroke participants will be randomized into four groups to receive either open placebo, sham rTMS, no intervention, or active rTMS over a two-week period. The findings could provide critical insights into the role of placebo in stroke recovery and improve clinical outcomes.
Why it matters
Potential benefit: If successful, this study could lead to improved rehabilitation strategies for stroke patients by leveraging the placebo effect.
How similar studies have gone: While the placebo effect has been studied in various contexts, this specific investigation into its neural mechanisms in stroke recovery is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Adults with hemiparesis due to chronic stroke 2. Stroke duration of 6 months or more 3. Fugl-Meyer scale upper extremity motor assessment score of \> 11 and ≤ 56 4. Pre-stroke disability (defined as a score of \< 3 on the Modified Rankin Scale) 5. Age 18 or older Exclusion Criteria: 1. Stroke of anterior cerebral artery territory with prefrontal lesion and stroke-related decreased EEG power in the prefrontal cortex 2. Unable to understand instructions 3. TMS contraindications: electronic hardware in close contact to the discharging coil such as cochlear implant, internal pulse generator or medical pump 4. Concurrent unstable medical conditions 5. A score of 24 or higher on the Hamilton Depression Rating Scale (HDRS) 6. Joint or paretic extremity pain likely to interfere with assessments 7. Pregnancy
Where it's running
-
Spaulding Hospital Cambridge
Cambridge, Massachusetts, United States Recruiting
Study contacts
- Principal investigator: Felipe Fregni, MD, PhD, MPH — Spaulding Rehabilitation Hospital/Harvard Medical School
- Study coordinator: Felipe Fregni, MD, PhD, MPH
- Email: fregni.felipe@mgh.harvard.edu
- Phone: 6179526156
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Quadriceps muscle activity and gait in people after stroke with stiff-knee gait vs healthy controls
We will test whether quadriceps muscle activity and walking movement differ between adults with post-stroke stiff-knee gait and healthy adults.
-
Home-based vs. in-clinic upper extremity rehabilitation after stroke
This study tests whether a 20-hour home telerehabilitation program (tele-CPASS) works as well as the same in-clinic CPASS therapy for improving arm and hand function after stroke.
-
Repetitive transcranial magnetic stimulation to improve heart-autonomic function after stroke
This test adds rTMS to usual neurological rehabilitation to see if it improves heart rate variability, autonomic symptoms, arm strength, and quality of life in people at least three months after a stroke.
-
Spatial StimelMD for upper-limb recovery after stroke or traumatic brain injury
This trial will test whether adding the Spatial StimelMD device to standard rehabilitation helps adults with upper-limb weakness after stroke or traumatic brain injury improve arm movement.
-
Deep phenotyping to explore recovery in young adults after stroke
This project will test whether a detailed health and sample-collection approach (deep phenotyping) is practical and acceptable for people aged 18–55 who have had a stroke.
-
Wrist-worn device to encourage use of the weaker arm after a recent stroke
This trial tests whether a wrist-worn sensor system plus motor and behavioral home coaching helps people 1–6 months after a stroke with moderate arm weakness use their affected arm more than a usual home-exercise program.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.